Orphan drug designation on brazil
In Brazil, a rare disease is the one affecting up to 65 people in every 100,000 individuals based on official national data. An orphan drug is a drug intended to treat, diagnose or prevent a rare disease.
About Global Regulatory Partners Inc:
Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and South Korea. GRP helps many life science companies register their products in different countries in compliance with local regulations.